All Medicines
Dr. Aditya Singh

Medically Reviewed By

Dr. Aditya Singh, MBBS, MD (Pharmacology)

Reg No: MCI-654321 • Verified Medical Reviewer

Immunostimulants

Xolremdi

(mavorixafor)

Uses, side effects, dosage information & price range

X4 Pharmaceuticals GmbH

About this medicine

Xolremdi is indicated in patients 12 years of age and older for the treatment of WHIM syndrome (warts, hypogammaglobulinemia, infections and myelokathexis) to increase the number of circulating mature neutrophils and lymphocytes.

Common Substitutes & Alternatives

These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.

AvonexComposition: interferon beta-1aBiogen Netherlands B.V.
Price on RequestView Details →
StrimvelisComposition: autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequenceFondazione Telethon ETS
Price on RequestView Details →
BesremiComposition: ropeginterferon alfa-2bAOP Orphan Pharmaceuticals GmbH
Price on RequestView Details →
RebifComposition: interferon beta-1aMerck Europe B.V.
Price on RequestView Details →
RyzneutaComposition: efbemalenograstim alfaEvive Biotechnology Ireland Limited
Price on RequestView Details →

Key Information

Salt / Composition

mavorixafor

Category

Immunostimulants

Manufacturer

X4 Pharmaceuticals GmbH

Need a doctor's consultation?

Don't self-medicate. Consult a doctor before taking any medicine.

Medical Disclaimer

This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.

Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.